Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
British Journal of Cancer|March 25, 2000
Extensive molecular screening for hereditary non-polyposis colorectal cancerB Dieumegard, S Grandjouan, J C Sabourin, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP)H Rubie, O Delattre, O Hartmann, et al.
Oncogene|May 21, 2008
Lobular and ductal carcinomas of the breast have distinct genomic and expression profilesF Bertucci, B Orsetti, V Nègre, et al.
British Journal of Cancer|March 4, 2010
High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease managementJ Dômont, S Salas, L Lacroix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie PédiatriqueH Rubie, O Hartmann, J Michon, et al.
International Journal of Cancer|March 27, 2001
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplificationD Plantaz, J Vandesompele, N Van Roy, et al.
Leukemia|July 1, 1997
French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de ParisS Chevillard, P Vielh, P Validire, et al.
British Journal of Cancer|October 31, 2014
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplificationR Defferrari, K Mazzocco, I M Ambros, et al.
British Journal of Cancer|December 8, 2011
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)G Schleiermacher, J Michon, A Ribeiro, et al.
Pageof 11